These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 16860046)

  • 1. Greater inhibition of the pituitary--ovarian axis in oral contraceptive regimens with a shortened hormone-free interval.
    Willis SA; Kuehl TJ; Spiekerman AM; Sulak PJ
    Contraception; 2006 Aug; 74(2):100-3. PubMed ID: 16860046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pituitary-ovarian hormone levels and symptoms in oral contraceptive users: comparison of a 21/7-day and extended regimen.
    Kuehl TJ; Speikermann AM; Willis SA; Coffee A; Sulak PJ
    J Reprod Med; 2008 Apr; 53(4):266-70. PubMed ID: 18472649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of pituitary-ovarian axis suppression with three oral contraceptive regimens.
    Vandever MA; Kuehl TJ; Sulak PJ; Witt I; Coffee A; Wincek TJ; Reape KZ
    Contraception; 2008 Mar; 77(3):162-70. PubMed ID: 18279685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects on serum hormone levels of low-dose estrogen in place of placebo during the hormone-free interval of an oral contraceptive.
    Reape KZ; DiLiberti CE; Hendy CH; Volpe EJ
    Contraception; 2008 Jan; 77(1):34-9. PubMed ID: 18082664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laboratory criteria for menopause in women using oral contraceptives.
    Creinin MD
    Fertil Steril; 1996 Jul; 66(1):101-4. PubMed ID: 8752618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary and ovarian hormone activity during the 7-day hormone-free interval of various combined oral contraceptive regimens.
    Cho M; Atrio J; Lim AH; Azen C; Stanczyk FZ
    Contraception; 2014 Jul; 90(1):94-6. PubMed ID: 24594430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FSH and ovarian response: spontaneous recovery of pituitary-ovarian activity during the pill-free period vs. exogenous recombinant FSH during high-dose combined oral contraceptives.
    van Heusden AM; Coelingh Bennink HJ; Fauser BC
    Clin Endocrinol (Oxf); 2002 Apr; 56(4):509-17. PubMed ID: 11966744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of serum and cervical mucus hormone levels during hormone-free interval of 24/4 vs. 21/7 combined oral contraceptives.
    Fels H; Steward R; Melamed A; Granat A; Stanczyk FZ; Mishell DR
    Contraception; 2013 Jun; 87(6):732-7. PubMed ID: 23352800
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitory effect of obesity on gonadotropin, estradiol, and inhibin B levels in fertile women.
    De Pergola G; Maldera S; Tartagni M; Pannacciulli N; Loverro G; Giorgino R
    Obesity (Silver Spring); 2006 Nov; 14(11):1954-60. PubMed ID: 17135611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dimeric inhibin serum values as markers of ovarian activity in pill-free intervals.
    Renier MA; Vereecken A; Van Herck E; Straetmans D; Ramaekers P; Vanderheyden J; Degezelle H; Buytaert P
    Contraception; 1998 Jan; 57(1):45-8. PubMed ID: 9554250
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ultrasonic and hormonal monitoring of the ovaries during mini-dose oral contraception].
    Doyen J; Schaaps JP; Lambotte R
    Contracept Fertil Sex (Paris); 1987 May; 15(5):529-33. PubMed ID: 12268693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of extended oral contraceptive regimens with a shortened hormone-free interval to manage breakthrough bleeding.
    Sulak PJ; Carl J; Gopalakrishnan I; Coffee A; Kuehl TJ
    Contraception; 2004 Oct; 70(4):281-7. PubMed ID: 15451331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinico-laboratory research on the pharmacodynamic characteristics of Rigevidon].
    Korkhov VV; Nikanorova SA
    Farmakol Toksikol; 1987; 50(1):97-100. PubMed ID: 3556564
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantifying effect of combined oral contraceptive pill on functional ovarian reserve as measured by serum anti-Müllerian hormone and small antral follicle count using three-dimensional ultrasound.
    Deb S; Campbell BK; Pincott-Allen C; Clewes JS; Cumberpatch G; Raine-Fenning NJ
    Ultrasound Obstet Gynecol; 2012 May; 39(5):574-80. PubMed ID: 21997961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibin B and ovarian function after total abdominal hysterectomy in women of reproductive age.
    Nahás E; Pontes A; Traiman P; NahásNeto J; Dalben I; De Luca L
    Gynecol Endocrinol; 2003 Apr; 17(2):125-31. PubMed ID: 12737673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of hormonal suppression with two contraceptive regimens using ethinyl estradiol and desogestrel.
    Gassen DT; Herter LD; Chagas JK; Schmid H
    Arch Gynecol Obstet; 2013 Feb; 287(2):289-94. PubMed ID: 22976131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian function with the contraceptive vaginal ring or an oral contraceptive: a randomized study.
    Duijkers IJ; Klipping C; Verhoeven CH; Dieben TO
    Hum Reprod; 2004 Nov; 19(11):2668-73. PubMed ID: 15333593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelationships of estradiol, inhibin, and gonadotropins during follicle deviation in pony mares.
    Donadeu FX; Ginther OJ
    Theriogenology; 2004 May; 61(7-8):1395-405. PubMed ID: 15036971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations in the ability of the bovine pituitary gland to secrete gonadotropins in vitro during the first follicle-stimulating hormone increase of the estrous cycle and in response to exogenous steroids.
    Lane EA; Padmanabhan V; Roche JF; Crowe MA
    Domest Anim Endocrinol; 2005 Feb; 28(2):190-201. PubMed ID: 15713366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of serum inhibin B measurement for evaluation of ovarian reserve in controlled ovarian hyperstimulation].
    Wu RR; Liao YC; Ye Y; Du Y; Ke WN; Zhang XB; Zhuang GL
    Zhonghua Fu Chan Ke Za Zhi; 2005 Oct; 40(10):679-81. PubMed ID: 16277899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.